Company Description
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific.
It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property.
The company provides scientific and academic research, a connect data, solutions, and expertise so that research institutions can thrive; ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats including data bases, dissertations, news, primary sources, books, and video; Alma, Polari, and Vega, a solution provides a proven, flexible, and unified library services platform for libraries to effectively manage their resources and unique materials.
It offers IPFolio and FoundationIP, manages platform that allows companies to secure, manage, and protect their IP assets through advanced workflow automation technology, superior data and analytics, and unparalleled industry expertise and support; patent services; Derwent Innovation patent search software helps patent professionals make faster, more patentability, freedom-to-operate, and validity decisions; and CompuMark trademark search solutions as well as trademark watch and other managed services.
In addition, the company provides Cortellis, a suite of products equip customers with the intelligence needed to make decisions spanning the entire drug development lifecycle.
It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations.
The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020.
Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
| Country | United Kingdom |
| Founded | 2016 |
| Industry | Information Technology Services |
| Sector | Technology |
| Employees | 12,000 |
| CEO | Matitiahu Shem Tov |
Contact Details
Address: 70 St. Mary Axe London, EC3A 8BE United Kingdom | |
| Phone | 44 20 7433 4000 |
| Website | clarivate.com |
Stock Details
| Ticker Symbol | CLVT |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001764046 |
| CUSIP Number | G21810109 |
| ISIN Number | JE00BJJN4441 |
| SIC Code | 7374 |
Key Executives
| Name | Position |
|---|---|
| Matitiahu Shem Tov | Chief Executive Officer and Director |
| Jonathan M. Collins | Executive Vice President and Chief Financial Officer |
| Gordon Samson | President of Intellectual Property |
| Bar Veinstein | President of Academia and Government |
| Henry Levy | President of Life Sciences and Healthcare |
| Michael Easton | Senior Vice President of Finance and Chief Accounting Officer |
| William E. Graff | Executive Vice President and Chief Information Officer |
| Mark J. Donohue CPA | Head of Investor Relations |
| John Doulamis | Senior Vice President and General Counsel |
| Tabita Andersson | Senior Vice President of Communications and Brand |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 28, 2025 | ARS | Filing |
| Mar 28, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 28, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 17, 2025 | PRE 14A | Other preliminary proxy statements |
| Feb 28, 2025 | 8-K | Current Report |
| Feb 19, 2025 | 10-K | Annual Report |
| Feb 19, 2025 | 8-K | Current Report |
| Dec 16, 2024 | 8-K | Current Report |
| Dec 13, 2024 | 8-K/A | [Amend] Current report |
| Dec 5, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |